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Abstract
Background: A robust method for Mendelian randomization does not require all genetic
variants to be valid instruments to give consistent estimates of a causal parameter.
Several such methods have been developed, including a mode-based estimation method
giving consistent estimates if a plurality of genetic variants are valid instruments; i.e.
there is no larger subset of invalid instruments estimating the same causal parameter
than the subset of valid instruments.
Methods: We here develop a model-averaging method that gives consistent estimates
under the same ‘plurality of valid instruments’ assumption. The method considers a mix-
ture distribution of estimates derived from each subset of genetic variants. The estimates
are weighted such that subsets with more genetic variants receive more weight, unless
variants in the subset have heterogeneous causal estimates, in which case that subset is
severely down-weighted. The mode of this mixture distribution is the causal estimate.
This heterogeneity-penalized model-averaging method has several technical advantages
over the previously proposed mode-based estimation method.
Results: The heterogeneity-penalized model-averaging method outperformed the mode-
based estimation in terms of efficiency and outperformed other robust methods in terms
of Type 1 error rate in an extensive simulation analysis. The proposed method suggests
two distinct mechanisms by which inflammation affects coronary heart disease risk, with
subsets of variants suggesting both positive and negative causal effects.
Conclusions: The heterogeneity-penalized model-averaging method is an additional ro-
bust method for Mendelian randomization with excellent theoretical and practical
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properties, and can reveal features in the data such as the presence of multiple causal
mechanisms.
Key words: Mendelian randomization, instrumental variables, robust methods, invalid instruments, model
averaging
Introduction
Mendelian randomization is an epidemiological approach
for making causal inferences from observational data by us-
ing genetic variants as instrumental variables.1,2 If a genetic
variant is a valid instrument for the risk factor, then any as-
sociation of the variant with the outcome is indicative of a
causal effect of the risk factor on the outcome.3 To be a
valid instrumental variable, a genetic variant must be:
• IV1: associated with the risk factor (relevance);
• IV2: independent of any confounder of the risk factor–
outcome association (exchangeable);
• IV3: independent of the outcome conditional on the risk
factor and confounders (exclusion restriction).
Violation of any of these assumptions means that an in-
strumental variable is not valid.
When there are multiple genetic variants that are all
valid instrumental variables, and under certain parametric
assumptions (most notably that all relationships between
variables are linear and there is no effect modification), an
efficient test of the causal null hypothesis as the sample
size increases can be obtained using the two-stage least-
squares method (based on individual-level data)4 or equiv-
alently the inverse-variance weighted (IVW) method (based
on summarized data).5 With uncorrelated instruments, the
IVW estimate [equal to the two-stage least-squares (2SLS)
estimate] is a weighted mean of the Wald (or ratio)
estimates obtained separately from each individual instru-
mental variable.
Whereas the 2SLS/IVW estimator is asymptotically effi-
cient, it is not robust to violations of the instrumental vari-
able assumptions. Specifically, if a genetic variant is a valid
instrument, then the ratio estimate based on that variant is
a consistent estimate of the causal effect. Hence the
weighted mean of these ratio estimates is a consistent esti-
mate of the causal effect if all genetic variants are valid
instruments, but not in general if at least one variant is not
a valid instrument.6 This has motivated the development of
robust methods for instrumental variable analysis based on
only a subset of the genetic variants being valid instru-
ments. For example, Kang et al.7 developed a method using
L1-penalization that gives consistent estimates if at least
50% of the instrumental variables are valid. Bowden et al.8
considered simple and weighted median methods that again
are consistent if at least 50% of the candidate instrumental
variables are valid; the simple median method is a median
of the variant-specific ratio estimates. Most recently, Guo
et al.9 introduced a method that provides a consistent esti-
mate if a plurality of the candidate instruments are valid,
meaning that the largest subset of genetic variants with the
same ratio estimate (in a large sample size) comprises the
valid instruments. Invalid instruments may have different
ratio estimates asymptotically, but the assumption is that
there is no larger subset of invalid instruments with the
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same ratio estimate than the subset of valid instruments.
Intuitively, this means that the true causal estimate can be
identified asymptotically as the mode of the variant-specific
ratio estimates. In parallel, Hartwig et al.10 have developed
a modal-based estimation method that can be implemented
using summarized data and provides a consistent estimate
under this plurality assumption, which they term the ‘zero
modal pleiotropy assumption’ (ZEMPA).
The idea of a modal-based estimate is an attractive one
due to the high breakdown point of the mode as an estima-
tor and its insensitivity to extreme values. However, there
are several issues with the implementations of Guo et al.
and Hartwig et al.’s methods that could be improved
upon. In particular, Hartwig et al.’s implementation of this
approach fits a kernel-density-smoothed function to the
variant-specific ratio estimates, and calculates confidence
intervals based on the median absolute deviation of a boot-
strapped distribution. Varying the bandwidth of the kernel
density can result in substantial changes to the estimate
and its confidence interval, as demonstrated later in this
paper. Guo et al.’s individual-level data method is imple-
mented by pairwise comparison of estimates from different
candidate instruments. When two genetic variants have
similar estimates, they ‘vote’ for each other. The overall es-
timate is based on the set of genetic variants with the great-
est number of these votes. However, as these binary votes
are determined by a fixed threshold, estimates from the
Guo et al. method (called ‘two-stage hard thresholding’)
will be sensitive to small changes in the data when the com-
parison measures are close to the threshold.
In this paper, we propose an alternative way of con-
structing a density function for the causal effect estimate as
a heterogeneity-penalized weighted mixture distribution.
This approach up-weights estimates that are supported by
multiple genetic variants, but severely down-weights hetero-
geneity. We show that the mode of this distribution will be
an asymptotically consistent estimator of the causal effect if
a weighted plurality of the genetic variants are valid instru-
ments. We first introduce this method, and then we demon-
strate its performance in a simulation study compared with
other robust methods. We consider its behaviour in two ap-
plied examples. Finally, we discuss the results of this paper
and their relevance to applied research. In particular, we con-
sider how to incorporate biological knowledge into the
weighting procedure. Software code for implementing the
proposed method is provided in Supplementary Material A.1,
available as Supplementary data at IJE online.
Methods
In this section, we first introduce the data requirements
and parametric assumptions necessary for summarized
data Mendelian randomization. We then recall the IVW
method, and subsequently introduce the model-averaging
procedure proposed in this paper.
Data requirements and assumptions
For practical reasons, many modern Mendelian randomi-
zation investigations are conducted using summarized data
on genetic associations with the risk factor (X) and out-
come (Y) taken from univariable regression models of
the risk factor (or outcome) regressed on the genetic var-
iants in turn.11 We assume, as is common in applied prac-
tice, that the genetic variants are all uncorrelated (not in
linkage disequilibrium). For each genetic variant Gj
(j ¼ 1;2; . . . ; J), we assume that we have an estimate b^Xj of
the association of the genetic variant with the risk factor
obtained from linear regression. Similar association esti-
mates are assumed to be available for the outcome (b^Yj).
The standard error of the association estimate with the
outcome is seðb^YjÞ. If any of the variables is binary, then
these summarized association estimates may be replaced
with association estimates from logistic regression; as has
been shown previously, the interpretation of the causal es-
timate in this case is not clear due to non-collapsibility, but
estimates still represent valid tests of the causal null hy-
pothesis.12,13 See Bowden et al.14 for a more detailed expo-
sition of the parametric assumptions typically made in
summarized data Mendelian randomization investigations
that are also made here.
IVW method
The ratio estimate based on genetic variant j is
h^j ¼ b^Yj=b^Xj, with standard error taken as seðh^jÞ ¼ seðb^YjÞ
=b^Xj (the leading order term from the delta expansion for
the standard error of the ratio of two variables). The IVW
estimate is a weighted mean of the ratio estimates:
h^IVW ¼
P
j h^jseðh^jÞ2P
j seðh^jÞ2
¼
P
j b^Yjb^Xjseðb^YjÞ2P
j b^
2
Xjseðb^YjÞ2
: (1)
The same estimate can be obtained from the weighted
regression:
b^Yj ¼ hIVW b^Xj þ j; j  Nð0; seðb^YjÞ2Þ: (2)
For uncorrelated variants, this estimate is also equiva-
lent to the estimate obtained from two-stage least-
squares—a method typically used for instrumental variable
analysis with individual-level data.5 These estimates do not
take into account uncertainty in the genetic associations
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with the risk factor; however, these associations are typi-
cally more precisely estimated than those with the out-
come, and ignoring this uncertainty does not lead to
inflated Type 1 error rates in realistic scenarios.15 This is
because genetic associations with the risk factor are typi-
cally estimated in larger sample sizes (as they are estimated
in cross-sectional datasets, whereas associations with dis-
ease outcomes are estimated in case–control studies), be-
cause risk factors are continuous (outcomes are often
binary) and because genetic variants are chosen as those
having strong associations with the risk factor. If these
conditions are not met, then alternative approaches are
possible.16 Additionally, we assume that the standard
errors of genetic associations are known without error; as
associations are typically estimated in large sample sizes,
this is usually a reasonable assumption.
The standard error of the IVW estimate based on a
fixed-effect meta-analysis model is:
seðh^IVWÞ ¼ 1ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiP
j seðh^jÞ2
q ¼ 1ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiP
j b^
2
Xjseðb^YjÞ2
q : (3)
We also consider a multiplicative random-effects model
based on the weighted linear regression above:
b^Yj ¼ hIVW b^Xj þ j; j  Nð0;w2seðb^YjÞ2Þ; (4)
where w is the residual standard error. Most statistical soft-
ware packages estimate this additional parameter by de-
fault in a weighted linear regression model. A fixed-effect
analysis can be performed by fixing the value of w to 1.17
To ensure that the standard error of the IVW estimate is
never more precise than that from a fixed-effect analysis,
we allow w to take values above 1 (corresponding to over-
dispersion of the genetic association estimates), but not
values below 1 (corresponding to under-dispersion). If all
genetic variants estimate the same causal parameter, then
w should tend to 1 asymptotically.
Heterogeneity-penalized model-averaging
method
We seek to define a function with the property that the
mode (the maximum value) of the function will tend to the
true causal effect when a plurality of the genetic variants
are valid instruments. For making statistical inferences, it
is convenient if this function is a likelihood for the causal
effect parameter. We present the method in a somewhat in-
formal way; a more technical explanation is provided in
Supplementary Material A.2, available as Supplementary
data at IJE online. We consider a model-averaging proce-
dure with 2J  J  1 candidate models, where J is the total
number of genetic variants. Each model corresponds to
one of the 2J  J  1 subsets of genetic variants (subsets in-
cluding 0 or 1 genetic variants are ignored throughout).
Our likelihood function is a mixture of 2J  J  1 normal
distributions, where the kth normal distribution has mean
and standard deviation corresponding to the IVW estimate
and standard error based on all the variants in the kth
subset:
h^IVW;k ¼
P
j2rk h^jseðh^jÞ
2P
j2rk seðh^jÞ
2 (5)
seðh^IVWr;kÞ ¼
w^kffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiP
j2rk seðh^jÞ
2
q ; (6)
where rk ¼ ðrk1;rk2; . . . ; rkJÞ : rkj 2 f0; 1g represents a
subset of the genetic variants, j 2 rk when rkj ¼ 1 (this
means that h^IVW;k is the IVW estimate based on all the var-
iants in subset k) and
w^k ¼ maxð1;
1
K 1
X
j2rk
seðb^YjÞ2 ðb^Yj  h^IVW;k b^XjÞ2Þ;
(7)
where K is the number of variants included in subset k.
The random-effects versions of the standard errors
seðh^IVWr;kÞ are used in this mixture distribution to appro-
priately allow for heterogeneity between the variant-
specific ratio estimates in the overall causal estimate (hence
the additional subscripted r).
The weight given to each of these normal distributions
is calculated as:
wk ¼
Y
j2rk
seðh^jÞ1 exp ðh^j  h^IVW;kÞ
2
2seðh^jÞ2
" #
: (8)
Aside from the constant term, this is a distance measure
that will be greater when more variants are included in the
subset k due to the seðh^jÞ1 terms, but they will reduce
sharply if there is more heterogeneity between the variant-
specific ratio estimates for variants in the subset than
would be expected due to statistical uncertainty alone if all
variants estimated the same causal parameter. If the
variant-specific ratio estimates for variants in a particular
subset substantially differ, then the weight for that subset
will be low. Note that the reason for excluding subsets
with one variant is that heterogeneity cannot be estimated
for these subsets. We then normalize the weights so that
they sum to 1:
w0k ¼
wkP
k wk
: (9)
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The causal estimate is the mode of the likelihood of the
mixture of normal distributions using these weights:
h^MODE¼ argmax
h
X
k
w0kseðh^IVWr;kÞ1 exp 
ðh h^IVW;kÞ2
2seðh^IVWr;kÞ2
" #
:
(10)
We use this likelihood for making inferences about the
causal effect h.
Consistency and efficiency
In the asymptotic limit for a fixed number of genetic var-
iants but as the sample size tends to infinity (and hence the
standard errors of the ratio estimates decrease to 0), the
weighted mixture distribution (i.e. the likelihood for h)
tends to a series of spikes about the IVW estimates based
on each subset of variants. The height of each spike
depends on the total weight of variants that have that
causal estimate, and the tallest spike is the estimate with
the greatest weight of evidence. The modal estimate will be
the IVW estimate corresponding to the subset k of variants
all having the same ratio estimate which has the greatest
product of the inverse standard errors of the ratio estimatesQ
j2rk seðh^jÞ
1. Therefore, a consistent estimate is obtained
under a Hartwig’s weighted ZEMPA assumption.10 The in-
tuition of this assumption is that a weighted plurality of
the genetic variants is required to be valid instruments (as
opposed to median-based methods that require a majority
or weighted majority of variants to be valid instruments).
The term ‘plurality’ is taken from the terminology of elec-
tions; a political party winning more votes than any other
is said to have a plurality of the votes. We note the similar-
ity between this procedure and maximum likelihood esti-
mation, which gives the mode of a likelihood as its point
estimate.
Under this assumption, the heterogeneity-penalized
model-averaging method is asymptotically efficient, as the
weight of the IVW estimate based on all the valid instru-
ments will increase to 1 as the sample size tends to infinity.
This can be seen as the weight for any subset containing
variants with different ratio estimates will decrease to 0
rapidly. The weight of the largest subset of variants
with the same ratio estimates will be the greatest of all sub-
sets by the ZEMPA assumption, and the ratio of this
weight to all other weights will increase to infinity as the
sample size increases. However, asymptotic efficiency is
not necessarily an important property in practice, as infi-
nite sample sizes are rarely encountered in applied investi-
gations. The model-averaging estimate should be efficient
for finite sample sizes when several variants have similar
ratio estimates.
Inferences on the weighted model-averaged
distribution
We perform causal inferences based on the model-
averaged distribution using a generalized likelihood ratio
test to construct a confidence interval. We take twice the
log-likelihood function, and construct a confidence interval
consisting of all points for which twice their log-likelihood
is within a given vertical distance from the modal estimate.
For a 95% confidence interval, this distance is 3.841 (95th
percentile of a chi-squared distribution with one degree of
freedom). This is based on the result that twice the differ-
ence in the log-likelihood at the estimate and at the true
value of the parameter has a chi-squared distribution (here
with one degree of freedom as the parameter is one-dimen-
sional). This results in inference without requiring resam-
pling techniques (such as bootstrapping). The confidence
interval is not guaranteed to be symmetrical or to be a sin-
gle range of values (see later for an example of a bimodal
mixture distribution resulting in a composite confidence
interval).
Practically, the modal estimate and confidence interval
were obtained using a grid search approach. The likelihood
was evaluated at a series of points (in the simulation study,
from –1 to þ1 at intervals of 0.001—so estimates and con-
fidence intervals were estimated to three decimal places).
The modal estimate was taken as the point with the great-
est value of the likelihood function, and the 95% confi-
dence interval was taken as the set of points for which
twice the log-likelihood was within 3.841 of the twice the
log-likelihood at the modal estimate. If the log-likelihood
function is multimodal, this may result in a composite con-
fidence interval that consists of more than one range of
values.
Simulation study
To consider the expected performance of this proposed
method in realistic situations as well as in comparison to
alternative robust methods, we perform a simulation study.
We consider four scenarios:
1. no pleiotropy—all genetic variants are valid instruments;
2. balanced pleiotropy (violation of assumption IV3)—
some genetic variants have direct (pleiotropic) effects
on the outcome, and these pleiotropic effects are
equally likely to be positive as negative;
3. directional pleiotropy (violation of IV3)—some genetic
variants have direct (pleiotropic) effects on the out-
come, and these pleiotropic effects are simulated to be
positive;
4. pleiotropy via a confounder (violation of IV2)—some
genetic variants have pleiotropic effects on the outcome
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via a confounder. These pleiotropic effects are corre-
lated with the instrument strength.
In the first three scenarios, the Instrument Strength
Independent of Direct Effect (InSIDE) assumption6 is satis-
fied; in Scenario 4, it is violated. This is the assumption re-
quired for the MR-Egger method to provide consistent
estimates. This choice of scenarios enables us to explore
cases where the consistency assumptions for the different
methods are satisfied and violated to provide a fair com-
parison between different methods.
We simulate data for a risk factor X, outcome Y, con-
founder U (assumed unmeasured) and J genetic variants
Gj; j ¼ 1; . . . ; J. Individuals are indexed by i. The data-
generating model for the simulation study is as follows:
Ui ¼
XJ
j¼1
fjGij þ Ui (11)
Xi ¼
XJ
j¼1
cjGij þUi þ Xi
Yi ¼
XJ
j¼1
ajGij þ hXi þUi þ Yi
Gij  Binomialð2;0:3Þ independently for all j ¼ 1; . . . ; J
Ui; Xi; Yi  Nð0;1Þ independently
cj  Uniformð0:03; 0:1Þ independently for all j ¼ 1; . . . ; J:
The risk factor and outcome are positively correlated
due to confounding even when the causal effect h is 0
through the unmeasured confounder U. The genetic var-
iants are modelled as single-nucleotide polymorphisms
(SNPs) with a minor allele frequency of 30%. A total of
J¼ 10 genetic variants are used in each analysis. As the
proposed model-averaging method calculates weights for
all 2J  J  1 possible models, the model scales exponen-
tially with the number of variants, and so including more
variants was not computationally feasible in a simulation
setting. For each of Scenarios 2 to 4, we considered cases
with two, three and five invalid instruments. For valid
instruments, the aj and fj parameters were set to 0. For in-
valid instruments, the aj parameters were either drawn
from a uniform distribution on the interval from –0.1 to
0.1 (Scenario 2) or from 0 to 0.1 (Scenario 3) or set to 0
(Scenario 4). The fj parameters were either set to 0
(Scenarios 2 and 3) or drawn from a uniform distribution
on the interval from –0.1 to 0.1 (Scenario 4). The causal
effect h was either set to 0 (no causal effect) or 0.2 (positive
causal effect). The cj parameters were drawn from a uni-
form distribution on 0.03 to 0.1, meaning that the average
value of the R2 statistic for the 10 variants across simulated
datasets was 1.0% (from 1.1 to 1.4% in Scenario 4) corre-
sponding to an average F statistic of 20.4 (from 23.4 to
27.5 in Scenario 4).
In total, 10 000 datasets were generated in each sce-
nario. We considered a two-sample setting in which genetic
associations with the risk factor and outcome were esti-
mated on non-overlapping groups of 20 000 individuals.
We compared estimates from the proposed heterogeneity-
penalized model-averaging method with those from a vari-
ety of methods: the standard IVW method, MR-Egger6
(both using random-effects), the weighted and simple me-
dian methods8 and the mode-based estimate (MBE) of
Hartwig et al.10 Each of the methods was implemented us-
ing summarized data only.
Results
Results for all of the methods are provided in Tables 1
(Scenario 1) and 2 (Scenarios 2 to 4). We provide the mean
estimate, the standard deviation of estimates, the mean
standard error (Table 1 only) and the empirical power of
the 95% confidence interval (the proportion of 95% confi-
dence intervals excluding the null; this is the Type 1 error
rate with a null causal effect). Results for the MBE method
are only provided for 1000 simulated datasets per scenario.
This is for computational reasons—the MBE method took
around 20 times longer to run than all the other methods
put together. Results for the MBE method correspond to
simple (unweighted) and weighted versions of the method
not assuming NOME (no measurement error) with the rec-
ommended bandwidth parameter from the modified
Silverman rule (/ ¼ 1)18; in total, 12 different versions of
the MBE method are proposed by Hartwig et al.
Table 1 shows the efficiency of the model-averaging
method when all genetic variants are valid instruments.
The method is considerably more efficient than the MR-
Egger and MBE methods, with less variable estimates and
greater power to detect a causal effect, and similar in effi-
ciency to the median-based methods. Coverage under the
null is conservative for all methods, but particularly for the
MBE and model-averaging methods.
Table 2 shows the robustness of the model-averaging
method in a range of invalid instrument scenarios. Type 1
error rates are well controlled (less than 7.5%) in all sce-
narios when 2 or 3 out of the 10 variants are invalid, and
generally below those of other methods even when 5 var-
iants are invalid. Compared with the model-averaging
method, Type 1 error rates with five invalid instruments
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for the MR-Egger method are lower in Scenario 3; how-
ever, they are far higher in Scenario 4, and the power of
the MR-Egger method to detect a positive causal effect was
low throughout. Equally, Type 1 error rates are slightly
lower for the simple median method in Scenario 4, but
higher in Scenario 3. The empirical power of the model-
averaging method to detect a causal effect was generally
lower than that for other methods. However, when a
method suffers from Type 1 error inflation, this compari-
son is not a fair one. The power of the model-averaging
method to detect a positive causal effect was not domi-
nated by any method that had well-controlled Type 1 error
rates. Indeed, in Scenario 2, the power of the model-
averaging method even exceeded that of the IVW method
with three and five invalid variants. This is because models
including the invalid variants are down-weighted in the
model-averaging method, whereas these variants inflate
the standard error in the IVW method. Similar patterns
were observed in the bias of estimates, with the model-
averaging method generally having low bias. Although
some methods were less biased in particular scenarios, no
method was less biased across all scenarios.
In comparison to the MBE method of Hartwig et al.,
Type 1 error rates for the model-averaging method were
slightly higher than those for the simple MBE method, but
lower than those for the weighted MBE method, particu-
larly in Scenario 4, where the Type 1 error rate for the
weighted MBE method was not well controlled even with
only two invalid instruments. Power to detect a positive
causal effect was greater for the model averaging than for
the simple MBE method in all cases by at least 10%, and
greater than for the weighted MBE method in all cases ex-
cept in Scenario 4, where the weighted MBE method had
inflated Type 1 error rates.
In an additional simulation, we considered the perfor-
mance of the model-averaging method with six invalid
instruments using the same sample size and a sample size
of 100 000 (five times the original sample size) for each of
the gene–risk factor and gene–outcome associations
(Supplementary Table A1, available as Supplementary data
at IJE online). Although all methods performed poorly
with the original sample size, in comparison with the IVW
and weighted median methods, for which bias was almost
identical for the two sample sizes, bias for the model-
averaging method reduced sharply as the sample size
increased. In comparison with the MBE method, the
model-averaging method performed similarly well with the
original sample size, but the improvement in bias and Type
1 error rate with the increased sample size was much better
for the model-averaging method, with little improvement
in Type 1 error rates for the MBE method. In a further sim-
ulation, we considered the performance of the model-
averaging method with four invalid instruments, but in
which all the invalid instruments were simulated to have
the same pleiotropic effect on the outcome (Supplementary
Table A2, available as Supplementary data at IJE online).
This resulted in a confidence interval that was not a single
range of values for around 18% of simulated datasets with
the majority of variants having a null causal effect. Despite
this, the median estimate from the model-averaging
Table 1. Mean, standard deviation (SD), mean standard error (mean SE) of estimates and empirical power (%) for Scenario 1 (all
variants valid instruments)
Method Scenario 1: all instruments valid
Mean SD Mean SE Power
Null causal effect: h ¼ 0
Inverse-variance weighted 0.001 0.072 0.077 3.9
MR-Egger 0.003 0.223 0.236 3.6
Simple median 0.001 0.092 0.105 2.1
Weighted median 0.002 0.086 0.096 2.8
Simple mode-based estimate (Hartwig) 0.003 0.113 0.149 0.3
Weighted mode-based estimate (Hartwig) 0.002 0.098 0.128 1.2
Heterogeneity-penalized model averaging 0.001 0.080 – 1.4
Positive causal effect: h ¼ þ0:2
Inverse-variance weighted 0.191 0.080 0.086 61.9
MR-Egger 0.130 0.250 0.263 7.0
Simple median 0.201 0.104 0.119 39.0
Weighted median 0.185 0.096 0.109 39.9
Simple mode-based estimate (Hartwig) 0.195 0.136 0.167 18.5
Weighted mode-based estimate (Hartwig) 0.172 0.115 0.142 22.4
Heterogeneity-penalized model averaging 0.188 0.090 – 38.8
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Table 2. Mean, standard deviation (SD) of estimates and empirical power (%) for Scenarios 2, 3 and 4. MBE, mode-based esti-
mate of Hartwig et al.10
Method Two invalid variants Three invalid variants Five invalid variants
Mean SD Power Mean SD Power Mean SD Power
Null causal effect: h ¼ 0
Scenario 2: Balanced pleiotropy, InSIDE satisfied
Inverse-variance weighted –0.001 0.140 6.3 0.002 0.163 7.5 0.000 0.202 7.8
MR-Egger 0.001 0.436 7.7 0.004 0.509 8.2 0.007 0.629 9.3
Simple median 0.000 0.113 3.8 0.002 0.129 5.5 0.000 0.175 10.2
Weighted median 0.001 0.109 5.2 0.001 0.125 7.5 0.000 0.178 15.0
Simple MBE 0.000 0.126 1.0 0.008 0.131 1.8 0.006 0.196 4.0
Weighted MBE 0.004 0.105 2.4 0.000 0.113 3.1 0.005 0.172 8.3
Model averaging 0.000 0.100 2.4 0.000 0.115 3.2 –0.001 0.187 6.0
Scenario 3: Directional pleiotropy, InSIDE satisfied
Inverse-variance weighted 0.136 0.101 10.8 0.206 0.113 20.9 0.342 0.131 52.2
MR-Egger 0.004 0.421 7.8 0.002 0.479 8.2 0.011 0.539 8.5
Simple median 0.065 0.104 5.2 0.113 0.118 11.1 0.273 0.172 44.5
Weighted median 0.054 0.104 6.9 0.096 0.123 13.1 0.225 0.182 40.9
Simple MBE 0.020 0.122 1.7 0.044 0.138 2.3 0.146 0.220 9.4
Weighted MBE 0.013 0.102 2.9 0.041 0.123 5.1 0.114 0.177 12.8
Model averaging 0.021 0.098 2.6 0.043 0.121 3.9 0.133 0.214 11.8
Scenario 4: Pleiotropy via confounder, InSIDE violated
Inverse-variance weighted 0.104 0.125 19.4 0.150 0.135 26.2 0.232 0.140 38.3
MR-Egger 0.240 0.433 35.9 0.304 0.440 39.0 0.401 0.411 40.7
Simple median 0.023 0.111 4.1 0.044 0.125 6.5 0.095 0.164 16.9
Weighted median 0.090 0.144 20.8 0.143 0.164 34.1 0.247 0.178 60.5
Simple MBE 0.018 0.133 2.6 0.043 0.155 4.5 0.091 0.194 12.5
Weighted MBE 0.072 0.171 16.4 0.128 0.197 28.2 0.216 0.204 47.6
Model averaging 0.023 0.118 4.3 0.050 0.146 7.4 0.139 0.206 22.1
Positive causal effect: h ¼ þ0:2
Scenario 2: Balanced pleiotropy, InSIDE satisfied
Inverse-variance weighted 0.193 0.143 33.3 0.188 0.168 26.5 0.195 0.206 19.5
MR-Egger 0.129 0.452 9.4 0.137 0.526 9.6 0.135 0.644 8.9
Simple median 0.204 0.127 34.6 0.200 0.143 33.2 0.206 0.191 33.0
Weighted median 0.186 0.122 36.4 0.186 0.140 36.2 0.190 0.188 37.0
Simple MBE 0.198 0.139 17.2 0.193 0.156 19.5 0.202 0.205 18.1
Weighted MBE 0.173 0.118 21.1 0.166 0.132 22.7 0.154 0.166 21.9
Model averaging 0.189 0.115 31.8 0.189 0.135 29.5 0.193 0.207 25.6
Scenario 3: Directional pleiotropy, InSIDE satisfied
Inverse-variance weighted 0.329 0.110 72.7 0.397 0.121 79.8 0.532 0.140 92.1
MR-Egger 0.138 0.432 9.5 0.140 0.486 9.8 0.136 0.552 9.4
Simple median 0.274 0.120 55.0 0.328 0.136 65.7 0.489 0.186 87.2
Weighted median 0.247 0.117 55.3 0.292 0.137 65.0 0.419 0.189 82.6
Simple MBE 0.216 0.141 20.8 0.254 0.154 26.1 0.356 0.226 39.3
Weighted MBE 0.187 0.117 24.8 0.211 0.122 31.0 0.283 0.165 48.0
Model averaging 0.218 0.116 41.8 0.243 0.136 43.9 0.339 0.218 52.6
Scenario 4: Pleiotropy via confounder, InSIDE violated
Inverse-variance weighted 0.298 0.131 63.5 0.343 0.140 66.6 0.426 0.146 74.4
MR-Egger 0.396 0.449 42.8 0.473 0.454 48.4 0.586 0.415 51.9
Simple median 0.232 0.125 42.7 0.252 0.139 45.7 0.304 0.176 53.2
Weighted median 0.285 0.156 62.1 0.338 0.175 71.5 0.444 0.184 85.4
Simple MBE 0.212 0.145 22.0 0.237 0.155 25.2 0.290 0.175 37.2
Weighted MBE 0.245 0.173 37.1 0.293 0.195 46.8 0.383 0.202 65.4
Model averaging 0.226 0.137 40.5 0.257 0.167 42.7 0.348 0.217 52.3
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method was close to unbiased, and Type 1 error rates were
at or below nominal levels.
Applied examples
We provide further illustration of the proposed model-
averaging method and other robust methods in two applied
examples. In the first example, all the variants have similar
ratio estimates whereas, in the second example, there is
marked heterogeneity in the variant-specific ratio estimates.
Further detail about the applied examples is given in
Supplementary Material A.5, available as Supplementary
data at IJE online.
Low-density lipoprotein cholesterol and coronary
artery disease (CAD) risk
We consider the causal relationship between low-density li-
poprotein (LDL) cholesterol and CAD risk based on eight
genetic variants having strong biological links with LDL-
cholesterol. Each of these variants is located in a gene region
that either encodes a biologically relevant compound to
LDL-cholesterol or is a proxy for an existing or proposed
LDL-cholesterol-lowering drug. Genetic associations with
LDL-cholesterol were obtained from the Global Lipids
Genetics Consortium’s 2013 data release19 and associations
with CAD risk from CARDIoGRAMplusC4D’s 2015 data
release.20 These associations are displayed graphically in
Figure 1 (left panel). Weights for the variants and subsets of
variants are displayed in Supplementary Figure A1, available
as Supplementary data at IJE online.
Inflammation and CAD risk
We also consider the causal relationship between inflam-
mation and CAD risk based on 17 genetic variants previ-
ously demonstrated to be associated with C-reactive
protein (CRP) at a genome-wide level of statistical signifi-
cance.21 The biological rationale for this analysis is not to
evaluate the causal role of CRP, as several of these genetic
variants are not specifically associated with CRP and hence
are not valid instruments as they violate the exclusion re-
striction assumption (they have an effect on the outcome
not via CRP). The causal role of CRP can be evaluated in a
Mendelian randomization analysis using genetic variants
in the CRP gene region—the region that encodes CRP.22
Rather, the biological rationale for this analysis considers
CRP as a proxy measure for inflammation more generally
and investigates whether there are any consistent causal
relationships between inflammation and CAD risk.
Genetic associations with CRP are obtained from Dehghan
et al.21 and associations with CAD risk from the
CARDIoGRAM consortium.23 These associations are dis-
played graphically in Figure 1 (right panel).
Results
Results for both examples are presented in Table 3.
Estimates represent log odds ratios for CAD per 1-mmol/L
increase in LDL-cholesterol or per unit increase in
log-transformed CRP. For the MBE method, we present
estimates for a range of values of the bandwidth in the
kernel-density estimator representing the suggested band-
width from the modified Silverman rule (/ ¼ 1), half the
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Figure 1. Genetic associations with risk factor and outcome (lines are
95% confidence intervals) for: (left) 8 genetic variants having biological
links to LDL-cholesterol; (right) 17 genetic variants associated with C-re-
active protein (CRP) at a genome-wide level of significance.
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suggested bandwidth (/ ¼ 0:5) and one-quarter of the sug-
gested bandwidth (/ ¼ 0:25), as well as for simple and
weighted versions of the method.
In the first example, all of the methods suggest a posi-
tive causal effect. In the model-averaging method, the
weight of the estimate including all eight variants is 12.1%
and estimates with seven or more variants comprise 42.1%
of the total weight (compared with 0.4% and 3.6% of
the weight with no heterogeneity penalization—equal
weights). The width of the confidence interval from the
model-averaging method is similar to that from the
weighted median method, and narrower than that from all
other methods except for the standard IVW method.
Confidence intervals from the MBE method are consider-
ably wider than those from other methods, and vary in size
by up to 40% for the different choices of bandwidth con-
sidered here. The improvement in efficiency of our method
compared with the best-case estimate from the MBE
method is a 1.54-fold reduction in the standard error.
Assuming that the standard error decreases proportionally
as the square root of the sample size, this improvement
would correspond to including an additional 98 000 cases
and 154 000 controls in the analysis. In the second exam-
ple, the methods give varied estimates. In particular, the
simple MBE method gives a positive estimate, whereas the
weighted MBE method gives a negative estimate with a
confidence interval that excludes 0. In contrast, the model-
averaging method gives a negative estimate, but a confi-
dence interval that includes both negative and positive
values, although excludes 0—it includes two disjoint
ranges of values. Again, the precision of the MBE estimates
varied for different choices of bandwidth, in the most ex-
treme comparison by almost a factor of two.
Figure 2 shows the mixture distributions of the IVW
estimates based on all subsets of genetics variants using
both equal weights (dashed line) and heterogeneity-
penalized weights (solid line) from the model-averaging
method. For the first example, the equally and penalized
weighted distributions are similar, as the IVW estimates
based on all subsets of variants are similar. For the second
example, the heterogeneity-penalized distribution differs
substantially from distribution using equal weights and is
bimodal, indicating that there are groups of variants hav-
ing similar weight of evidence supporting both a positive
and a negative causal effect, and suggesting that there are
causal mechanisms linked with inflammation that have
both protective and harmful effects on CAD risk. These
results could be driven by different inflammatory risk fac-
tors that are causally upstream of CRP and have different
directions of effect on the outcome. This explains the com-
posite confidence interval including both positive and neg-
ative values. Only the model-averaging method is able to
capture this feature of the data.
Discussion
The aim of this manuscript was to develop a mode-based
estimation method that provides a consistent estimate of
the causal effect under the assumption that a plurality of
the genetic variants are valid instruments. Although our
method is not the first to provide consistent estimates
under this assumption, we believe that our method has sev-
eral technical advantages over previously proposed meth-
ods. In comparison with the MBE method proposed by
Hartwig et al., our method: (i) does not rely on the specifi-
cation of a bandwidth parameter; (ii) makes inferences that
Table 3. Estimates (standard errors, SE) and 95% confidence intervals (CI) from a variety of methods for applied examples.
MBE, mode-based estimate of Hartwig et al.10
Risk factor: LDL-cholesterol C-reactive protein
Method Estimate (SE) 95% CI Estimate (SE) 95% CI
Inverse-variance weighted 0.585 (0.044) 0.499, 0.671 –0.135 (0.102) –0.334, 0.065
MR-Egger 0.611 (0.100) 0.415, 0.807 –0.223 (0.198) –0.611, 0.165
Simple median 0.561 (0.067) 0.429, 0.693 0.118 (0.155) –0.187, 0.422
Weighted median 0.585 (0.057) 0.473, 0.697 –0.303 (0.108) –0.515, –0.092
Simple MBE (/ ¼ 1) 0.522 (0.105) 0.316, 0.727 0.295 (0.372) –0.433, 1.023
Simple MBE (/ ¼ 0:5) 0.700 (0.136) 0.434, 0.966 0.285 (0.502) –0.698, 1.269
Simple MBE (/ ¼ 0:25) 0.699 (0.147) 0.411, 0.987 0.306 (0.510) –0.694, 1.305
Weighted MBE (/ ¼ 1) 0.686 (0.096) 0.498, 0.875 –0.407 (0.152) –0.705, –0.108
Weighted MBE (/ ¼ 0:5) 0.697 (0.140) 0.423, 0.971 –0.458 (0.112) –0.678, –0.238
Weighted MBE (/ ¼ 0:25) 0.696 (0.140) 0.421, 0.970 –0.472 (0.218) –0.898, –0.045
Heterogeneity-penalized model averaginga 0.598 0.475, 0.718 –0.441 –0.602, –0.257 and 0.038, 0.352b
aThe heterogeneity-penalized model-averaging method does not estimate a standard error. For the risk factor LDL-cholesterol, and assuming normality, the
standard error would be 0.062.
bThe confidence interval in this case is the union of two disjoint ranges.
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do not rely on resampling methods; (iii) makes no asymp-
totic assumption about the distribution of the causal esti-
mate for making inferences, in particular allowing
confidence intervals to be asymmetric and to span multiple
ranges; (iv) is asymptotically efficient, and should be effi-
cient in finite samples, as the method seeks to up-weight
the IVW estimate based on the largest number of variants
with homogeneous ratio estimates. One particular concern
with the MBE method is that the precision of the estimate
is highly variable, depending on the choice of bandwidth
parameter. There would be a great temptation as an ap-
plied researcher to perform the method for a variety of
values of the bandwidth parameter and choose the band-
width parameter corresponding to the most desirable
estimate.
The proposed heterogeneity-penalized model-averaging
method also outperformed Hartwig’s method in the simu-
lation study, and in the applied examples. No sizeable in-
flation in Type 1 error rates was observed across the
simulation scenarios when 2 or 3 of the 10 genetic variants
were invalid, and bias and Type 1 error rates were gener-
ally either better or no worse than for other robust meth-
ods. The method was also at least as efficient as other
robust methods when all variants were valid instruments
and had reasonable power to detect a causal effect
throughout.
One deficiency of the proposed method is computa-
tional time. Whereas the method was substantially quicker
than that of Hartwig et al. with 10 genetic variants, the
run-time of our method doubles with each additional vari-
ant. In the applied example with 17 genetic variants, 217
1 ¼ 131 071 weights were calculated. The method calcu-
lated weights in 0.7 seconds on a single 2.60-GHz central
processing unit (CPU). The grid search algorithm took a
further 34 seconds. However, with 30 genetic variants,
over 1 billion weights would need to be calculated.
Reducing the computational burden may be possible—e.g.
models including genetic variants with highly discrepant
ratio estimates would receive low weights and could be
dropped with little loss of accuracy. Alternatively, an algo-
rithm such as shotgun stochastic search24 may be able to
explore the parameter space in an efficient way. However,
solving this computational challenge in general is left as a
problem for future work.
A particular novel feature of the method is its ability to
identify multiple causal effects. Two categories of hetero-
geneity in the ratio estimates based on different variants
can be conceived: ‘random-effects’ heterogeneity and het-
erogeneity from variants linked with different causal mech-
anisms. As in meta-analysis, it is likely that there will be
some heterogeneity between ratio estimates from different
variants arising due to slight differences in causal mecha-
nisms, non-linearity of effects or non-homogeneity of
effects across individuals. This is dealt with in the model-
averaging model by allowing for over-dispersion in the
standard errors from the IVW method. Another type of
heterogeneity would occur if some genetic variants are in-
valid instruments and have incompatible ratio estimates;
this is dealt with in the model-averaging model by
upweighting evidence from the largest subset of variants
with mutually compatible ratio estimates. An interesting
case is if two or more sets of genetic variants have mutually
similar but distinct ratio estimates (as in the example of
CRP in the paper). This could occur for a complex risk
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Figure 2. Mixture distributions of IVW estimates using equal (dashed
line) and penalized (solid line) weights from model-averaging method
for: (left) LDL-cholesterol; (right) C-reactive protein (CRP). The right-
hand axis is twice the log-likelihood—the 95% confidence interval con-
tains all points within a vertical distance of 3.84 units on this scale (3.84
is the 95th percentile of a chi-squared distribution on one degree of
freedom).
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factor. For example, some genetic variants associated with
body mass index (BMI) affect metabolism, whereas others
may affect appetite. These two distinct biological processes
may have different magnitudes of causal effect on the out-
come. Future work would be beneficial to identify clusters
of genetic variants having similar causal estimates that
may reflect distinct causal mechanisms.
The heterogeneity-penalized model-averaging method is
likely to be affected by weak instruments in a similar way
to the IVW method, as it is based on a mixture of distribu-
tions centred on the IVW estimates. A weak instrument is
one that does not have a statistically strong association
with the risk factor.25 When genetic associations with the
risk factor and with the outcome are estimated in the same
individuals (a one-sample investigation), the IVW estimate
is biased by weak instruments in the direction of the obser-
vational association between the risk factor and outcome,
and Type 1 error rates are inflated. However, if genetic
variants are associated with the risk factor at a genome-
wide level of significance, bias should be minimal.26 When
genetic associations with the risk factor and with the out-
come are estimated in non-overlapping sets of individuals
(a two-sample investigation), as is common in Mendelian
randomization, bias due to weak instruments is in the di-
rection of the null and does not lead to inflated Type 1 er-
ror rates.27 Hence we would not expect weak instrument
bias to adversely affect Mendelian randomization investi-
gations using the model-averaging method in practice.
An extension of the method that could be valuable in
applied practice is the use of prior information on particu-
lar variants. This can be achieved by multiplying the
unnormalized weights wk by a prior weight p0ðkÞ before
normalizing. For example, if an investigator is particularly
confident that a genetic variant is likely to be a valid
instrument, then models containing this variant can be
up-weighted. Alternatively, prior weightings of models
containing specific variants could be based on biological
characteristics of the variants. For example, exonic and/or
non-synonymous variants could be up-weighted or variants
with functional information relating them to the risk factor.
If these variants truly are more likely to be valid instruments,
then this prior weighting would add to the robustness of the
method. Additionally, a prior weighting could be set to more
strongly up-weight less parsimonious models (i.e. up-weight
models based on more genetic variants). This could add effi-
ciency to the analysis, as models including more genetic var-
iants will have more precise IVW estimates. Equal prior
weights corresponds to a prior belief that 50% of genetic
variants are valid instruments. If one instead believed that
(say) 80% of genetic variants were valid instruments, then
the prior for subset k could be set to p0ðkÞ ¼ 0:8K  0:2JK,
where J is the total number of genetic variants and K is the
number of variants in subset k. The option to set this prior
probability is included in the software code.
Conclusion
In conclusion, the heterogeneity-penalized model-averaging
procedure introduced in this paper will be a worthwhile contri-
bution to the Mendelian randomization literature both in pro-
viding an additional robust method for causal estimation and
testing the causal null hypothesis when some genetic variants
may not be valid instruments and for revealing features in the
data such as the presence of multiple causal mechanisms.
Supplementary Data
Supplementary data are available at IJE online.
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